Literature DB >> 4679234

Radioimmunoassay of serum parathyroid hormone in postmenopausal osteoporosis.

T Fujita, H Orimo, K Okano, M Yoshikawa, R Shimo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4679234     DOI： 10.1507/endocrj1954.19.571

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN： 0013-7219


× No keyword cloud information.
  3 in total

1.  Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: evidence that skeletal sensitivity is increased.

Authors:  M A Kotowicz; G G Klee; P C Kao; W M O'Fallon; S F Hodgson; S L Cedel; E F Eriksen; D G Gonchoroff; H L Judd; B L Riggs
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

2.  Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.

Authors:  H Rico; A Charro; I Depablos; E Bordiu; E R Hernandez; D Espinos
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

3.  Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.

Authors:  Takuo Fujita; Masao Fukunaga; Akira Itabashi; Kiichiro Tsutani; Toshitaka Nakamura
Journal:  Calcif Tissue Int       Date:  2013-08-21       Impact factor: 4.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.